Thomas F. Ryan's most recent trade in Gardiner Healthcare Acquisitions Corp was a trade of 25,000 Common Stock, par value $0.0001 per share done . Disclosure was reported to the exchange on June 29, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gardiner Healthcare Acquis... | Thomas F. Ryan | Director | Other type of transaction at price $ 0.00 per share. | 29 Jun 2023 | 25,000 | 0 | - | - | Common Stock, par value $0.0001 per share | |
| Repligen Corp. | Thomas F. Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 1,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Thomas F. Ryan | Director | Sale of securities on an exchange or to another person at price $ 197.58 per share. | 01 Mar 2022 | 1,000 | 1,457 (0%) | 0% | 197.6 | 197,580 | Common Stock |
| Repligen Corp. | Thomas F. Ryan | Director | Sale of securities on an exchange or to another person at price $ 198.48 per share. | 01 Mar 2022 | 1,000 | 2,457 (0%) | 0% | 198.5 | 198,480 | Common Stock |
| Repligen Corp. | Thomas F. Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.76 per share. | 01 Mar 2022 | 1,000 | 3,457 (0%) | 0% | 38.8 | 38,760 | Common Stock |
| Repligen Corp. | Thomas F. Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 1,285 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Thomas F. Ryan | Director | Sale of securities on an exchange or to another person at price $ 302.00 per share. | 02 Nov 2021 | 1,285 | 13,337 (0%) | 0% | 302 | 388,070 | Common Stock |
| Repligen Corp. | Thomas F. Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 128.18 per share. | 02 Nov 2021 | 1,285 | 14,622 (0%) | 0% | 128.2 | 164,711 | Common Stock |
| Repligen Corp. | Thomas F. Ryan | Director | Sale of securities on an exchange or to another person at price $ 288.00 per share. | 02 Nov 2021 | 1,000 | 12,337 (0%) | 0% | 288 | 288,000 | Common Stock |
| Repligen Corp. | Thomas F. Ryan | Director | Sale of securities on an exchange or to another person at price $ 250.50 per share. | 04 Aug 2021 | 780 | 971 (0%) | 0% | 250.5 | 195,390 | Common Stock |
| Repligen Corp. | Thomas F. Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 1,151 | 1,151 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Thomas F. Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 457 | 1,751 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Thomas F. Ryan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Mar 2021 | 170 | 1,294 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Thomas F. Ryan | Director | Sale of securities on an exchange or to another person at price $ 205.00 per share. | 03 Mar 2021 | 1,000 | 1,464 (0%) | 0% | 205 | 205,000 | Common Stock |
| Repligen Corp. | Thomas F. Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2021 | 1,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Thomas F. Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.12 per share. | 03 Mar 2021 | 1,000 | 2,464 (0%) | 0% | 26.1 | 26,120 | Common Stock |
| Repligen Corp. | Thomas F. Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.76 per share. | 11 Nov 2020 | 934 | 2,398 (0%) | 0% | 38.8 | 36,202 | Common Stock |
| Repligen Corp. | Thomas F. Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2020 | 934 | 1,000 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Thomas F. Ryan | Director | Sale of securities on an exchange or to another person at price $ 187.73 per share. | 11 Nov 2020 | 934 | 1,464 (0%) | 0% | 187.7 | 175,340 | Common Stock |
| Repligen Corp. | Thomas F. Ryan | Director | Sale of securities on an exchange or to another person at price $ 151.96 per share. | 31 Jul 2020 | 2,109 | 2,450 (0%) | 0% | 152.0 | 320,484 | Common Stock |
| Repligen Corp. | Thomas F. Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2020 | 2,109 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Thomas F. Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.71 per share. | 31 Jul 2020 | 2,109 | 4,559 (0%) | 0% | 67.7 | 142,800 | Common Stock |
| Repligen Corp. | Thomas F. Ryan | Director | Sale of securities on an exchange or to another person at price $ 151.77 per share. | 31 Jul 2020 | 986 | 1,464 (0%) | 0% | 151.8 | 149,645 | Common Stock |